Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAsa Int Regulatory News (ASAI)

Share Price Information for Asa Int (ASAI)

Share Price is delayed by 15 minutes
Get Live Data
200.00    0.50 (0.25%)
Bid:
194.50
Ask:
200.00
Spread: 5.50 (2.828%)
Market Cap: £195.62m
ASAI Live PriceLast checked at - London Stock Exchange

Intraday Asa Int Share Chart

Stabilisation Notice

13 Jul 2018 07:01

RNS Number : 5199U
Citigroup Global Markets Limited
13 July 2018
 

Pre-stabilisation notice

 

13 July 2018

 

Not for release, publication or distribution, in whole or in part, directly or indirectly, in or into the United States of America, Australia, Japan, Singapore, the United Arab Emirates, the Kingdom of Saudi Arabia or any jurisdiction in which such distribution would be unlawful.

ASA International Group plc

 

Pre-Stabilisation Notice

Citigroup Global Markets Limited (Contact: Syndicate Desk +44 20 7986 9000) hereby gives notice that the Stabilising Manager named below and its affiliates may stabilise the offer of the following securities in accordance with Commission Delegated Regulation EU/2016/1052 under the Market Abuse Regulation (EU/596/2014) and the rules of the Financial Conduct Authority.

The securities:

Issuer:

ASA International Group plc

Securities:

Ordinary Shares with a par value of £1 each

ISIN:

GB00BDFXHW57

Offering size:

40,000,000 Ordinary Shares excluding the over-allotment option

Description:

Initial Public Offering of Ordinary Shares

Offer price:

313 pence per Ordinary Share

Associated securities:

There are no associated instruments that are subject to stabilisation

Stabilisation:

Stabilising Manager:

Citigroup Global Markets Limited, Citigroup Centre, Canada Square, Canary Wharf, London E14 5LB, United Kingdom

 

Stabilisation period expected to start on:

13 July 2018 (approximately 08.00 a.m. (London time))

Stabilisation period expected to end no later than:

10 August 2018 (close of business)

Existence, maximum size and conditions of use of over-allotment facility:

The Stabilising Manager may over-allot the securities to the extent permitted in accordance with applicable law, up to the maximum size of 4,000,000 Ordinary Shares.

Stabilisation trading venue:

London Stock Exchange plc, over-the-counter (OTC) and other order book venues e.g. Turquoise, BATS and Chi-X

Over-allotment Option:

Terms:

Catalyst Microfinance Investors has granted Citigroup Global Markets Limited, in its capacity as Stabilising Manager and for the account of the underwriters, the option to purchase, or procure purchasers for, up to an additional 4,000,000 Ordinary Shares at the offer price.

Duration:

This option may be exercised in full or in part at any time during the stabilisation period.

 

In connection with the offer of the above securities, the Stabilising Manager may over-allot the securities or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, there is no assurance that the Stabilising Manager will take any stabilisation action and any stabilisation action, if begun, may be ended at any time. Any stabilisation action or over-allotment shall be conducted in accordance with all applicable laws and rules.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction in which such an offer or solicitation is unlawful.

This announcement is addressed to and directed at persons in Member States of the European Economic Area ("Member States") who are "qualified investors" within the meaning of Article 2(1)(e) of the Prospectus Directive (Directive 2003/71/EC, as amended) and related implementation measures ("Qualified Investors"). In addition, in the United Kingdom, this announcement is being distributed only to, and is directed only at Qualified Investors who are, (i) persons who have professional experience in matters relating to investments falling within the definition of "investment professionals" in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "Order") and/or (ii) who are high net worth bodies corporate, unincorporated associations and partnerships or the trustees of high value trusts falling within Article 49(2)(a) to (d) of the Order, and (iii) other persons to whom it may otherwise lawfully be communicated (all such persons together being referred to as "Relevant Persons"). If you are not a Relevant Person, you should not act upon, or rely on, this announcement.

Neither this announcement nor any copy of it may be made or transmitted into the United States, or distributed, directly or indirectly, in the United States. Neither this announcement nor any copy of it may be taken or transmitted directly or indirectly into Australia, Canada, Japan, Hong Kong, India, Singapore, South Africa, the United Arab Emirates or the Kingdom of Saudi Arabia or to any persons in any of those jurisdictions, except in compliance with applicable securities laws. Any failure to comply with this restriction may constitute a violation of United States, Australian, Canadian, Japanese, Hong Kong, Indian, Singaporean, South African United Arab Emirates' or Saudi Arabian securities laws. The distribution of this announcement in other jurisdictions may be restricted by law and persons into whose possession this announcement comes should inform themselves about, and observe, any such restrictions.

This announcement is not an offer of securities for sale into the United States. The securities to which this announcement relates have not been and will not be registered under the US Securities Act of 1933, as amended (the "Securities Act") or with any regulatory authority or under any applicable securities laws of any state or other jurisdiction of the United States, and may not be offered or sold within the United States unless registered under the Securities Act or pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with applicable state law. There will be no public offer of the securities in the United States.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STARTMPTMBTBBPP
Date   Source Headline
3rd Jun 20262:14 pmRNSResult of 2026 Annual General Meeting
21st May 20267:00 amRNSDirector/PDMR Shareholding
6th May 20262:56 pmRNSDirector/PDMR Shareholding
5th May 20267:00 amRNSAppointment of Chairman and Board Update
30th Apr 20267:00 amRNSNotice of Annual General Meeting
30th Apr 20267:00 amRNSQ1 2026 Business Update
28th Apr 20267:00 amRNSAppointment of Independent Non-Executive Director
15th Apr 20267:00 amRNSFY 2025 Results
24th Feb 20267:00 amRNSDirector/PDMR Shareholding
6th Feb 20267:00 amRNSDirector/PDMR Shareholding
30th Jan 20261:31 pmRNSDirector/PDMR Shareholding
29th Jan 20267:00 amRNSQ4 2025 Trading and Business Update
13th Jan 20263:31 pmRNSHolding(s) in Company
9th Jan 20261:50 pmRNSDirector/PDMR Shareholding
9th Jan 20261:49 pmRNSDirector/PDMR Shareholding
19th Dec 202511:15 amRNS2025 Annual General Meeting Update Statement
19th Dec 202511:15 amRNS2025 Annual General Meeting Update Statement
17th Dec 20253:35 pmRNSAppointment of Non-Executive Director
4th Dec 20257:00 amRNSTrading Update
28th Nov 20259:36 amRNSHolding(s) in Company
10th Nov 20257:57 amRNSDirector/PDMR Shareholding
7th Nov 20259:38 amRNSHolding(s) in Company
6th Nov 20257:00 amRNSCFO Appointment
5th Nov 20255:31 pmRNSHolding(s) in Company
5th Nov 20255:27 pmRNSDirector/PDMR Shareholding
28th Oct 20252:20 pmRNSGrant of Options
27th Oct 20254:44 pmRNSDirector/PDMR Shareholding
21st Oct 20257:00 amRNSQ3 2025 Business Update
10th Oct 20253:29 pmRNSHolding(s) in Company
10th Oct 20253:28 pmRNSHolding(s) in Company
8th Oct 202512:44 pmRNSHolding(s) in Company
24th Sep 20257:00 amRNS2025 Interim Results
11th Aug 202512:20 pmRNSDirector/PDMR Shareholding
30th Jul 20254:32 pmRNSHolding(s) in Company
29th Jul 202511:12 amRNSHolding(s) in Company
23rd Jul 20259:40 amRNSDirector/PDMR Shareholding
22nd Jul 20257:00 amRNSQ2 2025 Business Update
19th Jun 20252:13 pmRNSResult of AGM
6th Jun 20257:00 amRNSDirectorate Change
20th May 20257:00 amRNSNotice of Annual General Meeting
24th Apr 20257:00 amRNS2024 Results
24th Apr 20257:00 amRNSAppointment of Independent Non-Executive Director
24th Apr 20257:00 amRNSQ1 2025 Business Update
20th Mar 20257:00 amRNSBoard and Leadership Update
10th Mar 202511:18 amRNSHolding(s) in Company
5th Mar 20254:27 pmRNSNotification of Major Holdings
5th Mar 20254:23 pmRNSNotification of Major Holdings
21st Jan 20257:00 amRNSQ4 2024 Trading and Business Update
8th Jan 20252:46 pmRNSDirector Remuneration Update
7th Jan 202512:14 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.